Estudo dos efeitos da terapia combinada orlistat / cisplatina / 5-fluorouracil / paclitaxel em linhagem metastática de carcinoma espinocelular de língua
Orientador: Edgard Graner === Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba === Made available in DSpace on 2018-08-24T18:26:23Z (GMT). No. of bitstreams: 1 Moreira_FernandadosSantos_M.pdf: 1478167 bytes, checksum: 57f6f26580823a79292af5a274beaa2d...
Similar Items
-
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
by: Yun Chen, et al.
Published: (2018-02-01) -
Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
by: Buxant F, et al.
Published: (2017-03-01) -
Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-10-01) -
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer
by: Vaibhav Sahai, et al.
Published: (2019-09-01) -
COMPARISON OF THE ANTIEMETIC EFFECTIVENESS BETWEEN GRANISETRON AND DEXAMETHASONE WITH ONDANSETRON AND DEXAMETHASONE IN ACUTE-PHASE CHEMOTHERAPY PATIENTS
by: Ria Fitrah Arfiani, et al.
Published: (2017-08-01)